22W0 Stock Chart & Stats
€0.04
>-€0.01(-1.97%)
At close: 4:00 PM EST
€0.04
>-€0.01(-1.97%)
Day’s Range― - ―
52-Week Range€0.01 - €0.15
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€2.48M
Enterprise Value€12.64M
Total Cash (Recent Filing)€975.00K
Total Debt (Recent Filing)€10.03M
Price to Earnings (P/E)―
Beta1.30
Next Earnings
Aug 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.28
Shares Outstanding73,026,810
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.69
Price to Sales (P/S)0.33
P/FCF Ratio-11.64
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.03
Revenue Forecast (FY)€29.36M
Bulls Say, Bears Say
Bulls Say
Manageable LeverageA moderate debt-to-equity ratio (0.48) and healthy equity ratio provide financial flexibility across the next 2-6 months. Manageable leverage reduces near-term covenant and interest pressure, helping the company fund brand investment and distribution activities without excessive refinancing risk.
Positive Gross MarginA positive gross margin shows the business can cover direct product costs and retain margin on sales. If SG&A and supply chain execution are tightened, this structural margin allows potential operating margin recovery and sustainable reinvestment in marketing and product development.
Modest Revenue GrowthConsistent, modest revenue growth indicates persistent demand and some distribution traction in pharmacy and retail channels. Over months, a growing top line provides runway to scale SKU economics, absorb fixed costs, and support strategic investment in brands if cash generation improves.
Bears Say
Negative Operating And Free Cash FlowPersistent negative operating and free cash flows constrain the firm's ability to fund inventory, marketing, and product rollout without external financing. Over 2-6 months this limits operational flexibility, raises refinancing or dilution risk, and can slow distribution expansion or brand building.
Ongoing Profitability WeaknessSustained negative net profit and EBIT margins indicate structural cost or pricing issues. Without durable margin improvement, the company cannot generate returns on equity, limiting reinvestment capacity and undermining competitive positioning in retail and pharmacy channels over the medium term.
Very Small Operating ScaleA headcount of three suggests very limited internal capacity across product, supply chain, and commercial functions. This small scale increases reliance on external partners, heightens execution risk for launches and distribution, and slows the pace at which the company can scale operations sustainably.
Wellnex Life Ltd News
22W0 FAQ
What was Wellnex Life Ltd’s price range in the past 12 months?
Wellnex Life Ltd lowest stock price was €0.01 and its highest was €0.15 in the past 12 months.
What is Wellnex Life Ltd’s market cap?
Wellnex Life Ltd’s market cap is €2.48M.
When is Wellnex Life Ltd’s upcoming earnings report date?
Wellnex Life Ltd’s upcoming earnings report date is Aug 28, 2026 which is in 26 days.
How were Wellnex Life Ltd’s earnings last quarter?
Wellnex Life Ltd released its earnings results on Feb 26, 2026. The company reported -€0.016 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.016.
Is Wellnex Life Ltd overvalued?
According to Wall Street analysts Wellnex Life Ltd’s price is currently Overvalued.
Does Wellnex Life Ltd pay dividends?
Wellnex Life Ltd does not currently pay dividends.
What is Wellnex Life Ltd’s EPS estimate?
Wellnex Life Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Wellnex Life Ltd have?
Wellnex Life Ltd has 73,026,810 shares outstanding.
What happened to Wellnex Life Ltd’s price movement after its last earnings report?
Wellnex Life Ltd reported an EPS of -€0.016 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.774%.
Which hedge fund is a major shareholder of Wellnex Life Ltd?
Currently, no hedge funds are holding shares in DE:22W0
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Wellnex Life Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
DE:22W0 Sentiment 100%
Sector Average ―
Sector Average ―
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-75.69%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-17.21%
Trailing 12-Months
Company Description
Wellnex Life Ltd
Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia, New Zealand, and the United Kingdom. The company offers topical anti-inflammatory creams, sprays, and roll-ons under the Pain Away brand; caffeine energy liquid capsules and multivitamins under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth whitening solutions under the Mr. Bright brand; pain relief capsules under the Wagner Liquigesics brand; medicinal cannabis under the Wellness Life brand; and over-the-counter medicines under the Pharmacy Own brand. It is also involved in the holding of intellectual properties and trademarks of its products; brand and pharma solution businesses; and investment activities. The company was formerly known as Wattle Health Australia Limited and changed its name to Wellnex Life Limited in June 2021. Wellnex Life Limited was incorporated in 2011 and is headquartered in Port Melbourne, Australia.
Technical Analysis
―
Bubs Australia Ltd.
―
Nuchev Pty Ltd
―
Holista Colltech Limited
―
Nutritional Growth Solutions Ltd.
―